Scandent Imaging Ltd
BSE:516110
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.9), the stock would be worth ₹0.03 (99% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 101.7 | ₹3.21 |
0%
|
| 3-Year Average | 0.9 | ₹0.03 |
-99%
|
| 5-Year Average | 1.5 | ₹0.05 |
-98%
|
| Industry Average | 7.3 | ₹0.23 |
-93%
|
| Country Average | 2.9 | ₹0.09 |
-97%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
S
|
Scandent Imaging Ltd
BSE:516110
|
173.4m INR | 101.7 | -3.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.6B USD | 0.4 | 56.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 0.4 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.4B USD | 0 | 12.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 1.5 | 23.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 1.4 | 18 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.9 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 12.3 | -27.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 1.4 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.9 |
| 70th Percentile | 5 |
| Max | 55 686.2 |
Other Multiples
Scandent Imaging Ltd
Glance View
Scandent Imaging Ltd. engages in the provision of medical, dental, and clinical services. The company is headquartered in Mumbai, Maharashtra. The firm specializes in and intends to provide scanning solutions to dental, and ear, nose and throat (ENT) network. The firm offers dental services, ENT services and radiographic reports. Its dental services include three-dimensional (3D)-Cone Beam Computed Tomography (CBCT) and two-dimensional (2D)-Digital Orthopantomogram (OPG). The firm offers images to view the hard tissues within the ear canal with a range of Field of View (FOV). The company offers radiographic reports as hard copy report/prints of selected scan images on radiographic plates and color prints of 3D images; e-mail report/ images as portable document format (Pdf) files; images and report on a compact disc (CD), and Digital Imaging and Communications in Medicine (DICOM) Data. The company also provides second opinion or over read interpretive services.
